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Retinal degeneration, characterized by the progressive death of retinal neurons, is the most 28 
common cause of visual impairment. Oxysterols are the cholesterol derivatives produced via 29 
enzymatic and/or free radical oxidation that regulate cholesterol homeostasis in the retina. 30 
Preclinical and clinical studies have suggested a connection between oxysterols and retinal 31 
degeneration. Here, we summarize early and recent work related to retina oxysterol-producing 32 
enzymes and the distribution of oxysterols in the retina. We examine the impact of loss of oxysterol-33 
producing enzymes on retinal pathology and explore the molecular mechanisms associated with the 34 
toxic or protective roles of individual oxysterols in different types of retinal degeneration.  We 35 
conclude that increased efforts to better understand the oxysterol–associated pathophysiology will 36 
help in the development of effective retinal degeneration therapies. 37 
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1 INTRODUCTION 78 
Oxysterols are a group of oxygenated products from cholesterol or its precursors (Guillemot-Legris 79 
et al., 2016). A single oxysterol can be produced by an enzyme-mediated reaction, a non-enzymatic 80 
route, or from a combination of both processes (Figure 1).  A sterol ring of cholesterol is oxidized by 81 
non-enzymatic routes including free radical and non-radical modification (Murphy and Johnson, 82 
2008) and endogenous oxysterols, such as 7-ketocholesterol (7-KC, abbreviations and nomenclature 83 
listed in Table S1) and 7β-hydroxycholesterol (7β-HC), are also predominantly produced via non-84 
enzymatic routes. A side chain of cholesterol is oxidized through enzymatic routes, typically 85 
catalysed by cytochrome P450 (CYP) enzymes. The CYP family members, including CYP3A4, CYP3A5, 86 
CYP7A1, CYP7B1, CYP11A1, CYP27A1, CYP39A1 and CYP46A1, are well characterised 87 
monooxygenases in oxysterol metabolism. CYP11A1 and CYP27A1 are localized to mitochondria, 88 
while the other CYP members are localized to endoplasmic reticulum (ER).  CYP3A4 coverts 89 
cholesterol to 4β-Hydroxycholesterol (4β-HC) and 25-Hydroxycholesterol (25-HC), while CYP3A5 90 
converts cholesterol only to 4β-HC (Bodin et al., 2002); CYP7A1 catabolizes cholesterol to 7α-91 
Hydroxycholesterol (7α-HC) and catabolizes 7-Dehydrocholesterol (7-DHC) to 7-ketocholesterol (7-92 
kC), while CYP7B1 oxidises 25-HC and 27-Hydroxycholesterol (27-HC) to, respectively, 7α,25-93 
Dihydroxycholesterol (7α,25-diHC) and 7α,27-Dihydroxycholesterol (7α,27-diHC); CYP11A1 94 
metabolizes cholesterol to 22(R)-Hydroxycholesterol (22R-HC) and from there to 20R,22R-95 
Dihydroxycholesterol (20R,22R-diHC) then to pregnenolone; CYP27A1 converts cholesterol to 25-HC 96 
or to 27-HC (predominant); CYP46A1 oxidises cholesterol to 24(S)-Hydroxycholesterol (24S-HC), 97 
which can be metabolised to 7α,24(S)-Dihydroxycholesterol (7α,24S-diHC) by CYP39A1. Some CYP 98 
enzymes can also oxidize cholesterol precursors to form oxysterols, such as CYP46A1 that 99 
metabolises cholesterol precursor, desmosterol, to 24(S),25-Epoxycholesterol (24S,25-EC). 100 
Enzymatically and non-enzymatically formed oxysterols can be transported to the liver where they 101 
are further converted to bile acids, which facilitates the elimination of excess cholesterol from 102 
extrahepatic tissues.  Oxysterols play an important role in a diverse range of cellular functions and 103 
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are involved in cancer, metabolic disorders and neurodegenerative diseases (Griffiths and Wang, 104 
2019; Guillemot-Legaris et al., 2016). 105 
      Retinal degeneration occurs in a group of retinopathies that are characterised by the progressive 106 
death of retinal neurons. There are different types of retinal degeneration, mainly classified either as 107 
inherited or complex retinal disorders. Inherited retinal degeneration, such as retinitis pigmentosa, is 108 
caused by genetic defects, primarily affecting photoreceptor cells; whereas complex retinal 109 
degeneration involves a combination of genetic and environmental risk factors and includes 110 
conditions such as diabetic retinopathy, age-related macular degeneration and glaucoma.  111 
Cholesterol is enriched in the neural retina and in retinal pigment epithelial (RPE) cells and plays a 112 
critical role in maintaining retinal function (Pikuleva and Curcio, 2014).  Major oxysterol-producing 113 
enzymes have been reported to be expressed in the retina and various oxysterols have been shown 114 
to be distributed in the retina (Fliesler and Bretillon, 2010; Pikuleva and Curcio, 2014). In this review 115 
we will discuss oxysterol metabolism in the retina and its function in retinal degeneration.              116 
2 RETINAL STRUCTURE AND FUNCTION 117 
The human retina is a 0.5mm-thick circular disc with a diameter of about 30-40mm that is positioned 118 
at the back of the eye. The retina is a highly organised light-sensitive structure which consists of a 119 
complex network of sensory neurons and associated cells which are tightly packed together (Figure 120 
2A). The photoreceptor cells are the initial light detecting cells and their capability to detect light is 121 
dependent on their interaction with the RPE cells.  122 
      As shown in Figure 2A the RPE in the vertebrate eye lies between the outer segments of the 123 
photoreceptors and the choroidal blood supply. It is composed of a single layer of tightly-packed 124 
columnar hexagonal epithelial cells containing pigment granules (melanin) and other organelles 125 
involved in the digestion of photoreceptor outer segment membranes into phagosomes (Hu et al., 126 
2008; Strauss, 2011). The melanosomes containing the pigment melanin are involved in the 127 
absorption of the light energy that strikes the retina. The RPE is aligned along Bruch’s membrane 128 
through its basolateral membrane. Bruch’s membrane provides a matrix essential for the interaction 129 
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of the RPE with blood flow in the capillaries of the choroid. The RPE therefore forms a tight-junction 130 
epithelium between the blood flow of the choroid and the outer photoreceptor segments, forming 131 
the outer blood-retinal barrier that enables selective permeability between the choroid and 132 
neurosensory retina (Steinberg, 1985; Strauss, 2011). This barrier is vital for the highly selective bi-133 
directional processes involving the transport of nutrients from the blood to the photoreceptors 134 
(choroid to retina) and for the movement of water and metabolites from the retinal side to the 135 
blood (retina to choroid) (Strauss, 2011). The pigments in the RPE absorb light and reduce its 136 
scattering, thereby improving image resolution and helping to protect the retina from any large 137 
influx of light. The RPE cells act as storage reservoirs of metabolites and vitamins and are critical for 138 
maintenance of retinal adhesion (Katz and Gao, 1995). 139 
      The retina is composed of at least six types of neural cells (rods, cones, bipolar, horizontal, 140 
amacrine and ganglion cells) and one type of glial cell (Muller glia) derived from the neural ectoderm. 141 
These cells are compactly arranged in several layers including the outer nuclear layer (ONL), outer 142 
plexiform layer (OPL), inner nuclear layer (INL), inner plexiform layer (IPL), ganglion cell layer (GCL) 143 
and nerve fibre layer (NFL) (Figure 2 A) (Purves et al., 2001). The human retina comprises over 110 144 
million rods and over 5 million cones (Remington, 2012) and these two types of photoreceptors are 145 
arranged in parallel fashion in the photoreceptor layer of the retina. Cones are responsible for 146 
photopic (bright illumination) central vision while the rods are responsible for scotopic (dim 147 
illumination) peripheral vision. Although rods outnumber cones by ~20 fold, cones are crucial for 148 
good visual acuity and colour discrimination. Human rods are highly sensitive, possessing the 149 
capacity to detect single photons, whereas each cone requires receipt of more than 100 photons to 150 
generate a comparable response (Mustafi et al., 2009). Phototransduction, in which a photon of light 151 
is changed to an electrical signal, takes place in the outer segments of the rod and cone 152 
photoreceptors. The electrical signals created by these retinal cells are then transferred via bipolar 153 
cells to the ganglion cells that convey the information to the brain through the optic nerve, resulting 154 
in the experience of vision (Remington, 2012). There is a striking difference in the circuitry 155 
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associated with rod and cone photoreceptors, specifically in the mode of transmission of signals 156 
from rods and cones to ganglion cells. Typically, a single cone cell communicates with a single bipolar 157 
cell that in turn transmits information to a single ganglion cell, whereas several rod cells can 158 
communicate with one bipolar cell, with several of the latter then feeding into a single ganglion cell. 159 
This convergence of signals by rods helps them to pool small signals in dim light, while the one-to-160 
one relationship between cones-bipolar-ganglion cells maximizes visual acuity (Solomon and Lennie, 161 
2007; Mustafi et al., 2009). 162 
3 CHOLESTEROL HOMEOSTASIS IN THE RETINA  163 
The retina has a well-regulated cholesterol input and output that maintains cholesterol homeostasis 164 
(Fliesler and Bretillon, 2010). The retina can directly take up cholesterol from the systemic 165 
circulation predominantly through a low-density lipoprotein receptor (LDLR)-mediated process in the 166 
RPE, which has LDLR localized to the basolateral side, facing the choroid (Tserentsoodolet et al., 167 
2006). Local cholesterol synthesis also contributes to cholesterol input in the retina. Lin et al. (2016) 168 
demonstrated that in situ biosynthesis of cholesterol accounted for 72% of the cholesterol input in 169 
mouse retina. Excess cholesterol in the retina is either removed via the reverse cholesterol transport 170 
(RCT) and/or metabolized to oxysterols by CYP enzymes (Fliesler and Bretillon, 2010); however, 171 
quantitative contributions of the RCT and oxysterol formation to the removal of excess cholesterol in 172 
the retina remain elusive.  Cholesterol efflux is the first step of the RCT pathway, which is mediated 173 
by acceptors (HDL and apolipoproteins) and ABC transporters (ATP Binding Cassette Subfamily A 174 
Member 1 (ABCA1), ATP Binding Cassette Subfamily G Member 1 (ABCG1) and ABCG4). Recent work 175 
from our laboratory and elsewhere has demonstrated effective cholesterol efflux in RPE and 176 
choroidal endothelial cells (Biswas et al., 2017; Lyssenko et al., 2018; Storti et al., 2017). 177 
      Proteins associated with regulation of cholesterol homeostasis (sterol regulatory element-178 
binding protein, SREBP; Sterol regulatory element binding proteins cleavage-activating protein, SCAP, 179 
insulin induced gene, INSIG; liver X receptor α and β, LXRα and LXRβ) are expressed in the retina 180 
(Zheng et al., 2012). SREBP-2 is the major regulator of cholesterol homeostasis. When intracellular 181 
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cholesterol is at a low level, SCAP escorts SREBP-2 from endoplasmic reticulum (ER) to the Golgi 182 
apparatus, where SREBP-2 is cleaved by two proteases, resulting in the release of the amino-183 
terminal of transcription factor functional domain and upregulation of cholesterol synthesis and 184 
uptake associated genes; when cholesterol level is high, cholesterol binds to SCAP and triggers SCAP 185 
physically interacting with INSIG, leading to retaining SCAP in the ER and blocking SREBP-2 186 
associated transcriptional activation (DeBose-Boyd et al., 1999; Hua et la., 1993; Yang et al., 2002). 187 
Furthermore, oxysterols inhibit cholesterol synthesis by binding to INSIG and preventing SREBP-2 188 
processing (Adams et al., 2004; Radhakrishnan et al., 2007). Additionally, oxysterols can regulate 189 
cholesterol homeostasis by activating the LXR signal pathway and enhancing cholesterol efflux (Fu et 190 
al., 2001; Janowski et al., 1999; Lehmann et al., 1997).    191 
4 OXYTEROLS IN THE RETINA  192 
4.1 Expression of major oxysterol-producing enzymes in the retina  193 
Some oxysterol-producing enzymes, such as CYP family members, have been shown to express in the 194 
retina (Figure 2B). Guarneri et al (1994) first reported that CYP11A1 was localized to ganglion cells 195 
and cells of the inner nuclear layer of rat retina; CYP11A was also shown to be similarly localized in 196 
hamster retina, although here its expression in the cells of the inner nuclear layer was higher than 197 
that in rat retina (Jaliffa et al., 2005). Lee et al (2005) examined expression of CYP27A1 in monkey 198 
retina and found that CYP27A1 was strongly expressed in photoreceptor inner segments and was 199 
also expressed at low levels in the RPE, choroid, ganglion cells, nerve fibres and Müller cells.  200 
CYP46A1 had higher mRNA levels in the neural retina and low levels in the RPE in bovine samples 201 
(Bretillon et al., 2007). CYP46A1 was strongly localized to ganglion cells and was also present in the 202 
inner nuclear layer of rat retina (Bretillon et al., 2007; Ishikawa et al., 2016); CYP46A1 also had 203 
similar localization in mouse retina (Ramirez et al., 2008). While CYP27A1 and CYP46A1 were also 204 
expressed in the human RPE cell line, ARPE-19 (Biswas et al., 2017) and monkey endothelial cell line, 205 
RF/6A (Biswas et al., 2018). In the human retina, mRNA of CYP11A, CYP27A1 and CYP46A1 has been 206 
detected in the neural retina and RPE. CYP11A was localized to ganglion cells and the cells of the 207 
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inner nuclear layer in both human and rodent retinas. CYP11A1 was also expressed in Bruch’s 208 
membrane, the RPE and photoreceptor inner segments in human retina. CYP27A1 was 209 
predominantly localized to Bruch’s membrane, RPE, photoreceptor inner segments, ganglion cells 210 
and nerve fibre layer. CYP46A1 had a localization in human retina similar to that of CYP27A1, 211 
although was expressed at a lower level (Zheng et al., 2012). Early work in the same lab 212 
demonstrated that CYP27A1 was expressed at a higher level in human neural retina (403-510 213 
fmol/mg protein) than was CYP46A1 (58-63 fmol/mg protein), while CYP27A1 was also expressed in 214 
human RPE at 1110-2060 fmol/mg protein, about 2.7-4.0-fold higher than in the neural retina (Heo 215 
et al., 2011; Liao et al., 2011). 216 
4.2 Distribution of oxysterol in the retina 217 
Based on the expression of oxysterol-producing genes (discussed above) and high level of oxidative 218 
stress (Wright et al., 2010), oxysterols in the retina are generated via enzymatic and radical reactions 219 
in a way similar to that seen in other tissues. A number of studies have examined oxysterols in the 220 
retinas of different species and found that oxysterols are present in the RPE, photoreceptor inner 221 
segments, ganglion cells and nerve fibre layer (Moreira et al., 2009; Rodriguez et al., 2014; Rodriguez 222 
and Fliesler, 2009) (Figure 2B). Moreira et al. (2009) examined oxysterols in primate retinas using 223 
high-pressure liquid chromatography-mass spectrometry (HLPC-MS) and immunohistochemistry. 7-224 
KC, which is predominantly generated by non-enzymatical oxidisation (Figure 1 and ref Anderson et 225 
al., 2020), was present in the neural retina at 1-1.5 pmol/nmol free cholesterol and in RPE/choroid at 226 
5-8 pmol/nmol free cholesterol.  Immunostaining showed that 7-KC was localized to monkey 227 
choriocapillaries, RPE and Bruch’s membrane (Moreira et al., 2009). Rodriguez and Fliesler (2009) 228 
investigated the effect of photodamage on generation of the oxysterols 7-KC and 7α/β-229 
hydroxycholesterol (7α/β-HC) in rat neural retina. They reported that light-treated rats had an 230 
approximately 6-fold increase in 7-KC (control rats: 1.6 pmol/nmol; treated rats: 12.7 pmol/nmol 231 
cholesterol) and a 50-fold increase in 7α/β-HC (control rats: trace only; treated rats: 25.0 pmol/nmol 232 
cholesterol), indicating increased production; further immunohistochemistry showed that the 233 
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increased 7-KC was localized to the RPE, photoreceptor inner segments and ganglion cells of 234 
photodamaged retinas (Rodriguez and Fliesler, 2009). In aged mice, a significantly high level of 7-KC 235 
was accumulated beneath the RPE (Indaram et al., 2015). 7-KC was also examined in bovine retina 236 
and was found to be lower in the neural retina (25 pmol/mg protein) than in the RPE (41 pmol/mg 237 
protein); a further two 7-KC-derived oxysterols, 3β,27-dihydroxy-5-cholesten-7-one (7-KCh-27OH) 238 
and 3 - hydroxy-5-cholesten-7-one-26-oic acid (7-KCh-27COOH), were detected at low levels in 239 
bovine RPE (7-KCh-27OH:  1 pmol/mg protein; 7-KCh-27COOH: not quantified) but not in the neural 240 
retina (Heo et al., 2011). Measurement of 7-KC in monkey neural retina and RPE/choroid 241 
demonstrated that 7-KC level was increased during aging and was 3-4 times higher in the 242 
RPE/choroid (1-68 pmol/nmol cholesterol) than in the neural retina (1-18 pmol/nmol cholesterol). 243 
Similarly, 7-KC in aged human RPE (2483.8 pmol/nmol cholesterol) was around 150 times higher 244 
than that in the neural retina (16.5 pmol/nmol cholesterol) (Rodriguez et al., 2014). Drusen, 245 
cholesterol- and lipid-rich extracellular deposits underneath the RPE, also contain an extremely high 246 
level of 7-KC (734.9 pmol/nmol cholesterol) (Curcio et al., 2005; Rodriguez et al., 2014). However, 7-247 
KC in human plasma is unaffected by aging and is not associated with age-related macular 248 
degeneration (AMD), the leading cause of blindness in aged population (Lin et al., 2018), suggesting 249 
increased in situ synthesis of 7-KC in neural retina and RPE with aging.           250 
      Using gas chromatography-mass spectrometry (GC-MS), Mast et al. (2011) examined the CYP 251 
enzymes-mediated oxysterol production: 24(S)-Hydroxycholesterol (24S-HC), produced by CYP46A1); 252 
27-Hydroxycholesterol (27-HC) and 3β-hydroxy-5-cholestenoic acid (27-COOH) (produced by 253 
CYP27A1); 22(R)-Hydroxycholesterol (22R-HC) and pregnenolone (produced by CYP11A1) in bovine 254 
and human retinas; they found abundant cholesterol (total) in the bovine neural retina (158 255 
nmol/mg protein) and RPE (136 nmol/mg protein) but detected very low levels of oxysterols, 256 
including 24S-HC (total) at 0.036 nmol/mg protein in retina and at 0.021 nmol/mgprotein in the RPE, 257 
22R-HC (total) at 0.007 nmol/mg protein in neural retina and at 0.010 nmol/mg protein in RPE, and 258 
pregnenolone (total) at 0.019 nmol/mg protein in the neural retina and at 0.029 nmol/mg protein in 259 
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the RPE. However, 27-HC was undetectable in both the bovine neural retina and RPE, 27-HC oxidized 260 
27-COOH (free) was present in both neural retina (0.025 nmol/mg protein) and RPE (0.09 nmol/mg 261 
protein), suggesting that when 27-HC is generated by CYP27A1, it might be immediately oxidised to 262 
27-COOH by the same enzyme. In the bovine choroid, only 24S-HC (total) and 22R-HC (total) were 263 
detected at, respectively, 0.018 nmol/mg protein and 0.001 nmol/mg protein. Furthermore, 264 
significantly higher amounts of 27-COOH (free) was found in human neural retina (0.037-0.125 265 
nmol/mg protein) than in the RPE (0.002-0.01 nmol/mg protein), while free 24S-HC and 266 
pregnenolone were detected at lower levels (0.001-0.004 nmol/mg protein for both) in the neural 267 
retina but was not detected at all in the RPE; free 22R-HC and 27-HC also were undetectable in both 268 
the neural retina and RPE (Mast et al., 2011; Liao et al., 2011).            269 
5 LOSS OF OXYSTEROL-PRODUCING ENZYMES IS ASSOCIATED RETINAL PATHOLOGY 270 
5.1 CYP27A1 and CYP46A1 271 
Mutations in the CYP27A1 gene cause cerebrotendinous xanthomatosis (CTX), which is a rare 272 
autosomal recessive metabolic disease that has systemic and neurological symptoms (Cruysberg et 273 
al., 1995; Dotti et al., 2001) and involves a variety of ocular abnormalities, including cataract, 274 
cholesterol-like crystals in the vitreous humour, premature retinal senescence, retinal vessel 275 
sclerosis, optic disk paleness, drusen and RPE defects (Cruysberg et al., 1995; Dotti et al., 2001; 276 
Morgan et al., 1989). Cyp27a1-/- mice have been extensively characterized. Such mice do not exhibit 277 
the classic CTX symptoms such as cataract, xanthomas in tendon and brain, and atherosclerosis 278 
(Honda et al., 2001; Repa et al., 2000; Rosen et al., 1998). However, retinal pathology in Cyp27a1-/- 279 
mice was first characterised in Dr Pikuleva’s laboratory (Omarova et al., 2012). Cyp27a1-/- mice 280 
demonstrated defects in retinal cholesterol homeostasis and developed cholesterol deposits 281 
beneath the RPE, neovascularization and Müller cell activation (Omarova et al., 2012).      282 
      Cyp46a1-/- mice demonstrated a greater than 40% reduction in cholesterol turnover in the brain 283 
but had a similar level of hepatic cholesterol and bile acid synthesis (Lund et al., 2003). Saadane et al 284 
(2019) examined the systemic and retinal cholesterol metabolism and retinal phenotypes. The 285 
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systemic cholesterol metabolism of the Cyp46a1-/- mice did not change significantly but did exhibit 286 
dysregulation of retinal cholesterol homeostasis. Vision function testing found no differences in 287 
either scotopic (rod function) or photopic (cone function) electroretinogram (ERG) between wildtype 288 
and Cyp46a1 deleted mice; however, Cyp46a1-/- mice demonstrated venous beading, tortuosity, 289 
increased vascular permeability and microglial activation in the retina (Saadane et al., 2019). Since 290 
CYP27A1 and CYP46A1 are the main enzymes for cholesterol metabolism in the retina, the same 291 
group also examined retinal pathology of Cyp27a1-/-/Cyp46a1-/- mice and found that these animals 292 
had significantly higher levels of retinal cholesterol compared to Cyp27a1-/- or Cyp46a1-/- alone; the 293 
mutant animals also developed abnormal retinal vasculature and had macrophage/microglial 294 
activation and increased oxidative stress in the retina. ERG tests showed that both scotopic and 295 
photopic ERGs were significantly lower in male double knockout mice when compared to the 296 
wildtype male mice (Saadane et al., 2014). Sterol-O-acyltransferase 1 (SOAT1) is responsible for 297 
cholesterol esterification in the retina (Saadane et al., 2016), leading to production of cholesterol 298 
esters, which are a significant component of drusen (Curcio et al., 2005). Apolipoprotein E (APOE), a 299 
major apolipoprotein in the retina, regulates cholesterol homeostasis as an acceptor for cholesterol 300 
efflux or a ligand for LDLR (Mazzone and Reardon, 1994; Zhao and Mazzone, 1999). To further 301 
investigate the associated function of CYP27A1 and CYP46A1 with SOAT1 or APOE in cholesterol 302 
metabolism, Petrov et al. (2019) generated Cyp27a1−/−/Cyp46a1−/−/Soat1-/- and 303 
Cyp27a1−/−/Cyp46a1−/−/ Apoe-/- mice, whose retinal structure and vasculature were normal. 304 
Cyp27a1−/−Cyp46a1−/−/Soat1-/- mice were found to have a normal retinal cholesterol level similar to 305 
that of Soat1-/- mice, but the Cyp27a1−/−/Cyp46a1−/− mice had a high level of retinal cholesterol, 306 
suggesting a possible compensatory response in cholesterol synthesis. However, 307 
Cyp27a1−/−/Cyp46a1−/−/Apoe-/- mice had a level of retinal cholesterol similar to that of Apoe-/- mice. 308 
All Cyp27a1−/−Cyp46a1−/−/Soat1-/- mice exhibited markedly decreased scotopic ERGs, with decreased 309 
photopic ERGs seen only in the male mice.  Soat1-/- mice had similar trends of decreased ERGs to 310 
that of Cyp27a1−/−/Cyp46a1−/−/Soat1-/- mice, indicating that cholesterol esterification is required for 311 
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retinal function. Only male Cyp27a1−/−/Cyp46a1−/−/Soat1-/- mice had a significant decrease in both 312 
scotopic and photopic ERGs (Petrov et al., 2019). 313 
5.2 DHCR7 314 
      7-dehydrocholesterol reductase (DHCR7) is the final enzyme of the Kandustch -Russel pathway in 315 
the cholesterol biosynthesis pathway and converts 7-dehydrocholesterol (7-DHC) to cholesterol. 316 
Mutations of the DHCR7 gene cause Smith-Lemli-Opitz syndrome (SLOS), which is an autosomal 317 
recessive metabolic disorder that is characterised by increased 7-DHC and reduced cholesterol in all 318 
tissues, malformation in multiple organs and mental retardation (Nowaceyk and Irons, 2012). SLOS 319 
patients also present with a wide range of ocular abnormalities, such as sclerocornea, cataract, 320 
paleness of optic discs and optic atrophy (Elias et al., 2003; Garry et al., 2010; Kretzer et al., 1981). 321 
Pathological analysis of a one-month-old SLOS male patient’s eye samples showed generally normal 322 
retinal structure, suggesting that loss of DHCR7 may not affect early retinal development; 323 
nevertheless, there was extensive death of ganglion cells, disintegration of mitochondria in the RPE, 324 
and accumulation of cytoplasmic material underneath photoreceptors (Kretzer et al., 1981). SLOS 325 
children have been shown to have defects in rod and rod-derived functions, showing slow kinetics of 326 
phototransduction activation and deactivation, possibly due to dysfunction of membrane-associated 327 
phototransduction proteins (Elias et al., 2003). A follow-up study examined visual function by ERG 328 
testing of the same patient cohort with long-term supplementation with dietary cholesterol. 329 
Compared to the controls, patients exhibited a significant decrease in the rod response but no 330 
difference in the cone response, suggesting that additional dietary cholesterol may protect cone 331 
function in SLOS patients (Garry et al., 2010).      332 
     Retinal function of DHCR7 has been studied in rodent models. Dhcr7 null mice have significantly 333 
increased 7DHC and markedly decreased cholesterol in serum and tissues. These mice also 334 
recapitulate some SLOS phenotypes, such as retardation of intra-uterine growth and craniofacial 335 
abnormality (Fitzky et al., 2001; Wassif et al., 2001). However, Dhcr7 mutant mice only survive 18-24 336 
hours after birth, limiting the application of the model for further phenotypic characterization.  An 337 
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alternative SLOS rat model has been developed by treating normal rats with trans-N,N-bis[2-338 
Chlorophenylmethyl]-1,4-cyclohexanedimethanamine dihydrochloride  (AY9944), a selective 339 
inhibitor for DHCR7. AY9944-treated rats recapitulate SLOS phenotypes (Kolf-Clauw et al., 1996). 340 
When pregnant rats were fed with AY9944 from gestational day 6 till postnatal day (P) 28, and their 341 
offspring also received AY9944 treatment from birth to P28, the pups at P28 exhibited abnormal 342 
accumulation of 7-DHC and markedly reduced cholesterol in serum, liver, retina and brain when 343 
compared to control animals; however, there was no defect in retinal development or change in ERG 344 
function, indicating that loss of DHCR7 may not affect retinal development (Fliesler et al., 1999). 345 
When AY9944 treatment of the progeny was extended from 4 to 10 weeks, the offspring 346 
demonstrated retinal degeneration with shorter outer segments, reduced thickness of outer nuclear 347 
layer and decreased ERG amplitudes, along with abnormal ultrastructure of RPE cells, when 348 
compared to the control animals (Fliesler et al., 2004).  349 
      Retinal degeneration in AY994-treated rodents is supposed to be caused by 7-DHC-derived 350 
oxysterols (Fliesler and Xu, 2018). 7-DHC is a strong reactive lipid molecule, sensitive to free radical 351 
oxidation, so generation of oxysterols from 7-DHC is predominantly via nonenzymatic oxidation but 352 
also via enzymatic oxidation (Fliesler and Xu, 2018; Xu et al., 2008). Xu et al. (2010) firstly identified 353 
fourteen novel oxysterol species from 7-DHC via free radical oxidation and found the oxysterol 354 
mixture is toxic to Neuro2a cells at ≥10 µM possibly via inhibition of proliferation and induction of 355 
differentiation (Korade et al., 2010; Xu et al., 2010). 7-DHC derived oxysterols have been identified 356 
and are accumulated in blood, liver, brain and retina of AY9944-exposed rats, particular 7-KC in the 357 
AY9944-treated retina is more than 30 times higher compared to that of the controls (Xue et al., 358 
2011, 2012). Intravitreal injection of 7-KC caused pan-retinal degeneration in normal rats, indicating 359 
the toxicity of 7-KC (Xu et al., 2012). Further in vitro experiments demonstrated that 7-DHC-derived 360 
oxysterols, including 7-KC, caused toxicity to mouse cone, monkey RPE and rat Müller glial cells 361 
(Pfeffer et al., 2016). The cause of retinal degeneration by 7-DHC-derived oxysterols in AY9944-362 
treated rats must at least be partially due to oxidative damage, given that co-treatment with 363 
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cholesterol and antioxidants is more effective in protecting against retinal degeneration in AY9944-364 
treated rats than treatment of rats with cholesterol alone (Fliesler et al., 2018).    365 
5 OXYSTEROLS AND AGE RELATED MACULAR DEGENERATION 366 
Age-related macular degeneration (AMD) is a chronic disease that affects the macula, the central 367 
cone dominated feature of the retina (Mitchell et al., 2018). The disease affects an ageing 368 
demographic and inevitably causes a loss of central vision due to growing abnormalities within the 369 
macula. AMD is one of the leading causes of visual loss in the developed world, particularly in those 370 
of Caucasian ethnicity (Mitchell et al., 2018). This degenerative condition is becoming increasingly 371 
prevalent due to an ageing population with predictions suggesting that AMD will double in 372 
frequency over the next two decades (Robman et al., 2017). AMD is a complex, multifactorial 373 
disease process. Aging is known to be the single most significant risk factor, but both genetic and 374 
environmental factors also contribute significantly to AMD etiology. When AMD has progressed to 375 
its late stage, it is classified into two major forms: dry (geographic atrophy) and wet (choroidal 376 
neovascularisation, CNV). The wet type is the significantly less common (about 10%) of the two, but 377 
its progression is fast and severe, accounting for 90% registration of legal blindness caused by AMD. 378 
While there is no effective treatment for dry AMD, anti-VEGF therapy is effective in wet AMD, 379 
causing regression of CNV and preservation of visual function (Mitchell et al., 2018). 380 
      The clinical hallmark of AMD is abnormal accumulation beneath the RPE of extracellular deposits 381 
(drusen) and basal linear deposits (BLinD) (Pikuleva and Curcio, 2014). Histopathological analyses has 382 
shown that cholesterol is enriched in these deposits, suggesting that defective RCT may play an 383 
important role in the pathogenesis of AMD (Curcio et al., 2001, 2005; Wang et al., 2010). RPE cells 384 
progressively degenerate in AMD, leading to the death of photoreceptors in the macula. The RPE 385 
cells are responsible for cholesterol homeostasis in the retina by supplying cholesterol to 386 
photoreceptor cells and by clearing excess cholesterol into the choriocapillaries via the RCT (Biswas 387 
et al., 2017; Lyssenko et al., 2018; Storti et al., 2017). Oxysterol-producing genes are abundantly 388 
expressed in the RPE (Heo et al., 2011; Liao et al., 2011; Zheng et al., 2012), which is exposed to a 389 
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high level of oxidative stress (Datta et al., 2017). Oxidative stress is proposed to induce cholesterol 390 
oxidation, so oxysterols may be actively produced in the RPE via enzymatic and free radical reactions. 391 
In fact, oxysterol species have been detected and localized to the RPE (Figure 2B) and there may be a 392 
functional role for 7-KC, 24S-HC and 27-HC in AMD.            393 
      The extremely high levels of 7-KC in the aged RPE and drusen, coupled with an observed increase 394 
of 7-KC in the RPE as a result of photodamage, support the notion of a link between 7-KC and AMD 395 
(Moreira et al., 2009; Rodriguez and Fliesler, 2009; Rodriguez et al., 2014). Early work showed that 7-396 
KC treatment decreased cell viability, induced cell death and increased ROS production in human 397 
RPE cells (Ong et al., 2003; Dugas et al., 2010; Olivier et al., 2016; Rodriguez et al., 2004) and in 398 
porcine RPE cells (Joffre et al., 2007). 7-KC is the most abundant oxysterol in oxidized LDL (ox-LDL) 399 
(Brown et al., 1996; Oh et al., 2016). Ox-LDL induces inflammation in the RPE and choroidal 400 
endothelial cells (Biswas et al., 2017, 2018). 7-KC treatment also induced production of inflammatory 401 
cytokines including IL-1β, Il-6, IL-8, IL-18, TNF-α in RPE cells (Dugas et al., 2010; Huang et al., 2012; 402 
Joffre et al., 2007; Larrayoz et al., 2010; Moreira et al., 2009; Shi et al., 2015; Yang et al., 2019), 403 
possibly via MAPK/ERK, Akt/PKB, PKC and NF-kB pathways (Larrayoz et al., 2010; Moreira et al., 2009; 404 
Yang et al., 2019). Huang et al (2012) reported that 7-KC also caused endoplasmic reticulum (ER) 405 
stress in human RPE cells. Given that the RPE is responsible for the daily renewal of the 406 
photoreceptor outer segment via phagocytosis, impaired or decreased phagocytosis is likely to 407 
contribute to AMD (Kevany and Palzewski, 2010). Recently, it has been shown that intravitreal 408 
injection of 7-KC in rats has resulted in disorganised and decreased apical microvilli of RPE and 409 
detachment of apical microvilli from the photoreceptor outer segments, leading to defects in outer 410 
segment phagocytosis (Yang et al., 2019).   411 
      Retinal microglia are resident macrophages that are distributed in the inner retina of young, 412 
healthy individuals. With aging or under stress conditions, these microglia migrate to the outer 413 
retina and become activated, demonstrating proinflammatory and proangiogenic properties. 414 
Microglial activation is associated with various types of retinal degeneration, including AMD 415 
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(Karlstetter et al., 2015). 7-KC has been reported to co-localize with subretinal microglia in aged mice. 416 
7-KC chemoattractively influenced microglial migration to the subretinal space and enhanced 417 
microglial activation, indicated by inflammasome activation, increased expression of 418 
proinflammatory cytokines (IL-1β, IL-6, IL-18 and TNFα) and of proangiogenic factors (VEGF, PDGFb 419 
and ICAM). Conditional culture media from 7-KC-exposed microglia stimulated endothelial cell 420 
migration, while transplantation of 7-KC-exposed microglia in a Matrigel-induced CNV model 421 
significantly promoted CNV formation (Indaram et al., 2015). 422 
      24S-HC can directly cross the blood-brain barrier and be transported to the liver by circulating 423 
lipoproteins, facilitating cholesterol elimination from the brain (Björkhem, 2006). 24S-HC also 424 
functions as an activator for nuclear transcription factors, such as LXR α and β (Lehmann et al., 1997), 425 
to upregulate expression of cholesterol transport genes including ABCA1 in both glial cells and 426 
neurons (Fukumoto et al., 2002) and APOE in astrocytes (Liang et al., 2004), leading to increased 427 
cholesterol efflux and mediation of cholesterol homeostasis. Additionally, 24S-HC can suppress 428 
Amyloid beta (Aβ) production by hindering amyloid precursor protein trafficking in Alzheimer’s 429 
models (Urano et al., 2013). Aβ has been localized to the drusen of AMD patients and is thought to 430 
contribute to AMD pathogenesis (Isas et al., 2010; Luibl et al., 2006). Anti-amyloid therapy 431 
suppresses retinal damage and retards vision loss in an AMD mouse model (Ding et al., 2011). 432 
Although 24S-HC is reported to be higher in the plasma of AMD patients than that of controls (Lin et 433 
al., 2018), the level of 24S-HC in the retina and RPE of AMD patients may be different.  So we 434 
propose that 24S-HC may play a protective role in AMD by enhancing cholesterol transport and 435 
reducing Aβ formation in neural retina and the RPE.   436 
       27-HC is undetectable in neural retina and RPE, possibly due to being immediately oxidized to 437 
27-COOH by CYP27A1 (Mast et al., 2011). Although there is no difference in plasma 27-HC levels of 438 
AMD patients and controls (Lin et al., 2018), we believe there to be a connection between 27-HC and 439 
AMD based on our recent work (Biswas et al., 2017, 2018). The translocator protein TSPO is a 440 
mitochondrial membrane protein that is responsible for delivering cholesterol from the 441 
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mitochondrial outer membrane to the inner membrane where it is metabolized to 27-HC by 442 
CYP27A1. In turn, 27-HC activates LXR signalling to upregulate the expression of ABCA1, ABCG1/4 443 
and APOE and promotes cholesterol transport in non-steroidogenic cells, including the RPE (Figure 3) 444 
(Biswas et al., 2017; Papadopoulos et al., 2015). We found that TSPO is expressed in the human RPE 445 
and monkey choroidal endothelial cells. In mouse retina, its expression was extremely high in the 446 
RPE and was seen to decline with age. Knockout of TSPO resulted in decreased cholesterol efflux and 447 
cholesterol accumulation in the RPE cells. TSPO ligands (FGIN-1-27, XBD173 and Etifoxine) promoted 448 
cholesterol efflux in the RPE and choroidal endothelial cells and upregulated expression of oxysterol 449 
metabolism and cholesterol trafficking genes; TSPO ligands also suppressed oxidized LDL-induced 450 
oxidative stress and inflammation (Biswas et al., 2017, 2018). The data suggests that TSPO-mediated 451 
cholesterol trafficking via 27-HC may play an important role in the pathogenesis of AMD.                   452 
7 OXYSTEROLS AND GLAUCOMA 453 
Glaucoma is a leading cause of irreversible blindness; currently affecting nearly 80 million individuals 454 
worldwide and predicted to increase to 111.8 million by 2040 (Tham et al., 2014). Glaucoma is 455 
characterised by the gradual degeneration of the optic nerve and retinal ganglion cell (RGC) loss 456 
(Almasieh et al., 2012; Weinreb et al., 2014). As RGCs are non-dividing cells without the capacity for 457 
regeneration, the damage of the optic nerve appears to be irreparable. Loss of RGCs is a complex 458 
process, associated with deprivation of neurotrophic factors, failure of axonal transport, 459 
mitochondrial dysfunction, neurotoxicity (oxidative stress, inflammation and excitotoxic damage) 460 
and defects in RGC-glia interaction (Almasieh et al., 2012). Glaucoma is classified in two main types: 461 
primary open-angle glaucoma (POAG) and primary angle-closure glaucoma (PACG). Most cases are 462 
POAG and involve a long-term increase in intraocular pressure (IOP). Glaucoma is a complex disease 463 
associated with multiple risk factors such as age, genetic background and hyperlipidemia (Wang and 464 
Bo, 2019; Weinreb et al., 2014). IOP is considered to be the most common risk factor for glaucoma, 465 
and reducing IOP is a well-established clinical approach to slowing glaucomatous degeneration. 466 
Although reducing IOP is therapeutically effective in retarding glaucoma progression, there is some 467 
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evidence that disease progression is still inevitable (Heijl et al., 2002; Kass et al., 2002), suggesting 468 
that neuroprotectants are urgently needed to prevent the degeneration of RGC and optic nerve. 469 
      The link between 24S-HC and glaucoma was first proposed when a polymorphism (rs754203) in 470 
the intron 2 of CYP46A1 gene was shown to be associated with increased risk for POAG (Fourgeux et 471 
al., 2009). Further work found that elevated IOP in the rat caused a transient increase in expression 472 
of CYP46A1 but no change in the retinal 24S-HC between experimental and contralateral eyes 473 
(Fourgeux et al., 2012). Inhibition of CYP46A1 in rats by intraperitoneal injection with voriconazole, 474 
which has been shown to effectively inhibit CYP46A1 in vitro and in vivo (Shafaati et al., 2010), led to 475 
a 37% decrease in retinal 24S-HC and impaired inner retinal function (ERG test); however, the effect 476 
of CYP46A1 inhibition on GCL was not examined (Fourgeux et al., 2014). Ishikawa et al. (2016) found 477 
elevated IOP significantly enhanced CYP46A1 expression at mRNA and protein levels in an ex vivo rat 478 
glaucoma model, while increased CYP46A1 protein was predominantly localized to ganglion cells. 479 
Retinal 24S-HC was also increased under conditions of high IOP. The authors also demonstrated that 480 
high pressure (75 mMHg) caused damage to the RGCs and that 24S-HC counteracted the damaging 481 
effects in a dose-dependent manner. 24S-HC also protected the RGCs from voriconazole-induced 482 
damage (Ishikawa et al., 2016). The data suggest that 24S-HC may have a protective role in 483 
conditions of high-IOP that are associated with glaucoma.   484 
8 OXYSTEROL-TARGETED THERAPEUTIC STRATEGIES FOR RETINAL DEGENERATION 485 
8.1 Small chemical therapy 486 
The development of oxysterol-targeted therapy will depend on the functional properties of 487 
individual oxysterols. For example, when targeting 7-KC, a strategy is needed to inhibit 7-KC-induced 488 
toxicity (e.g. oxidative damage and inflammation) and/or to convert 7-KC to less- or non-toxic 489 
metabolites; for 24S-HC and 27-HC, ideally there should be more in situ biosynthesis.  Sterculic acid 490 
has been shown to inhibit 7-KC-induced cell death and inflammation in RPE cells and suppressed 491 
laser-injury-induced CNV formation in rats (Huang et al., 2012). Resveratrol, a natural polyphenol, 492 
has also been shown to reduce 7-KC-induced RPE apoptosis and VEGF section (Dugas et al., 2010). 493 
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There are other candidates that are worth investigating further. Efavirenz, an anti-HIV drug, has 494 
been shown to activate CYP46A1 and improve behaviour in the 5XFAD Alzheimer’s disease mouse 495 
model (Mast et al., 2017; Petrov et al., 2019). It would be useful to assess the therapeutic potential 496 
of Efavirenz via 24S-HC function in both AMD and glaucoma models. TSPO ligands, such as XBD173, 497 
promote mitochondrial cholesterol trafficking and increase the metabolism of cholesterol to 27-HC, 498 
which upregulates cholesterol transport and metabolism genes via activation of the LXR signal 499 
pathway, consequently enhancing intracellular cholesterol removal (Papadopoulos et al., 2015). 500 
TSPO ligands have been shown to suppress oxidized LDL-induced oxidative stress and inflammation 501 
in the RPE and choroidal endothelial cells (Biswas et al., 2017, 2018). XBD173 can also inhibit 502 
microglial activation and attenuate light-induced retinal degeneration (Scholz et al., 2015). 503 
Evaluation of the protective effects of XBD173 against 7-KC-induced oxidative damage, inflammation 504 
and microglia activation may help to develop new treatments for AMD.             505 
8.2 Gene therapy  506 
Gene therapy is one possible means by which to increase levels of oxysterol-producing enzymes in 507 
the retina. Currently, this appears to be a safe and feasible approach for the treatment of inherited 508 
retinal degeneration. Adeno-associated virus (AAV) is a commonly used vector for delivery, targeting 509 
genes in the retinal cells such as photoreceptors and RPE cells (Lee et al., 2019). Hudry et al (2010) 510 
over-expressed CYP46A1 via AAV-mediated gene therapy in the cortex and hippocampus of 511 
Alzheimer’s disease mice and found that the level of 24S-HC in the brain was significantly increased, 512 
while formation of Aβ deposits and Aβ-associated pathology were markedly reduced (Hudry et al., 513 
2010). AAV-mediated overexpression of CYP46A1 in the striatum globally regulates cholesterol 514 
metabolism and improves behavioural and neuronal functions in Huntington’s disease mouse model 515 
(Kacher et al., 2019). Similarly, overexpression of CYP46A1 in ganglion cells via gene delivery may 516 
help to prevent glaucoma. CYP27A1 is the main enzyme responsible for elimination of 7-KC in the 517 
RPE (Heo et al., 2011); it also metabolizes cholesterol to 27-HC, which promotes cholesterol efflux in 518 
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the RPE (Biswas et al., 2017). Potentially, then, overexpression of CYP27A1 in the RPE using gene 519 
therapy could be a new therapeutic strategy for AMD.     520 
9 CONCLUSIONS 521 
Enriched expression of oxysterol-producing enzymes and the distribution of oxysterols in the retina 522 
suggest that oxysterols may have multiple functions in the pathogenesis of degenerative retinal 523 
diseases. This review summarizes our current understanding of oxysterol biology in the retina, 524 
including biosynthesis, metabolism, function and association with retinal degeneration. Current 525 
preclinical and clinical data suggest that 7-KC, 24S-HC and 27-HC are the major oxysterols associated 526 
with retinal degeneration. More effort is required to establish a deeper understanding of oxysterol-527 
related pathophysiology in retinal degeneration and to develop new therapeutic interventions to 528 
improve visual function in oxysterol-associated retinal disorders.    529 
9.1 Nomenclature of targets and ligands 530 
Key protein targets and ligands in this article are hyperlinked to corresponding entries in 531 
http://www.guidetopharmacology.org, the common portal for data from the IUPHAR/BPS Guide to 532 
PHARMACOLOGY (Harding et al., 2018), and are permanently archived in the Concise Guide to 533 
PHARMACOLOGY 2019/20 (Alexander et al., 2019a,b,c).  534 
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Figure legends 925 
Figure 1 Structure of oxysterols generated in retina and RPE. The main oxysterols that are oxidized 926 
from cholesterol or its precursors in either enzymatic or non-enzymatic way. The enzymatic 927 
oxygenation reactions are mainly mediated by cytochrome P-450 family (green arrows). The non-928 
enzymatic oxysterol-generating reactions are catalysed by reactive oxygen species (ROS) (red arrow).  929 
 930 
Figure 2 Retinal structure and localization of oysterols and major oxysterol-metabolism enzymes. (A) 931 
Structure of human eye and retina. Left panel: Human retina (yellow) is located on the rear 932 
hemisphere of the eyeball. From outermost to innermost the layers are the sclera, the choroid and 933 
the retina. The macula is an oval pigmented area located at the central retina where the highest 934 
concentration of cones is found. Retinal blood vessels enter the retina in conjunction with the optic 935 
nerve, with branches distributing in the choroid layer. The cornea is a transparent layer at the front 936 
of the eye, lying anterior to the iris and pupil. Right panel: human retina consists of different types of 937 
cells: retinal pigment epithelium (RPE) cells, rod photoreceptors, cone photoreceptors, bipolar cells, 938 
horizontal cells, amacrine cells, ganglion cells and Müller cells. They form several layers of the retina 939 
(from outermost to innermost): outer nuclear layer (ONL), outer plexiform layer (OPL), inner nuclear 940 
layer (INL), inner plexiform layer (IPL), ganglion cell layer (GCL) and nerve fibre layer (NFL). Müller 941 
cells span the entire retina. (B) Distribution of oxysterol-producing enzymes and presentation of 942 
main oxysterols in the retina.  943 
 944 
Figure 3 TSPO-mediated cholesterol efflux in retinal pigment epithelial (RPE) cells. The RPE uptakes 945 
low-density lipoproteins (LDL) from the choroidal circulation mainly via LDL receptor (LDLR). 946 
Cholesterol is released from LDL degradation in the RPE and delivered to the mitochondria, where 947 
cholesterol is transported from mitochondrial outer membrane (MOM) to mitochondrial inner 948 
membrane (MIM) by TSPO protein complex containing TSPO, steroidogenic acute regulatory protein 949 
(StAR, not shown), the voltage dependent anion channel (VDAC), the adenine nucleotide 950 
38 
 
translocator (ANT) and other regulatory proteins (not shown). Oxysterol is generated by CYP27A1 to 951 
27-hydroxycholesterol (27-OHC), which upregulates expression of cholesterol transports (e.g. ABCA1 952 
and ABCG1A) via activation of the liver-X receptor (LXR) signalling pathway and enhances cholesterol 953 
efflux. Ligands can bind TSPO, enhance mitochondrial cholesterol trafficking and promote 954 
cholesterol efflux. BrM, Bruch’s membrane; MOM: Mitochondrial outer membrane; MIM: 955 
Mitochondrial inner membrane; MM: Mitochondrial matrix; IPM, interphotoreceptor matrix; ApoA1: 956 
Apolipoprotein A1; ApoE: Apolipoprotein E; ABCA1: ATP-binding cassette transporter member 1; 957 


































































Table S1 Abbreviation and nomenclature of oxysterols 1016 
Abbreviation Common name Systemic name Lipid Map ID 
4β-HC 4β-hydroxycholesterol Cholest-5-en-3β,4β-diol LMST01010014 
7α-HC 7α-hydroxycholesterol Cholest-5-en-3β,7α-diol LMST01010013 
7-DHC 7-dehydrocholesterol Cholesta-5,7-dien-3β-ol LMST01010069 









7α,25-diHC 7α,25-dihydroxycholesterol Cholest-5-en-3β,7α,25-triol LMST04030166 






22R-HC 22(R)-Hydroxycholesterol Cholest-5-en-3β,22R-diol LMST01010086 




25-HC 25-Hydroxycholesterol Cholest-5-en-3β,25-diol LMST01010018 
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